Integrative and Comparative Biology · 2007 · 105 citations · 46 references
Life SciencesBiologyEvolutionary BiologyCarcinogenesisEvolutionary TheoryNeoplasiaCancer RiskMalignant NeoplasmsMalignant TumorsNatural SelectionTumor BiologyTumor Growth KineticsBody Size AdaptationCancer Risk AssessmentCarcinogenic ResponseNatural Selection SignaturesSize-selective MortalitySpecies Differences In CarcinogenesisWildlife Cancer Ecology
Larger organisms have more potentially carcinogenic cells, tend to live longer and require more ontogenic cell divisions. Therefore, intuitively one might expect cancer incidence to scale with body size. Evidence from mammals, however, suggests that the cancer risk does not correlate with body size. This observation defines "Peto's paradox." Here, we propose a novel hypothesis to resolve Peto's paradox. We suggest that malignant tumors are disadvantaged in larger hosts. In particular, we hypothesize that natural selection acting on competing phenotypes among the cancer cell population will tend to favor aggressive "cheaters" that then grow as a tumor on their parent tumor, creating a hypertumor that damages or destroys the original neoplasm. In larger organisms, tumors need more time to reach lethal size, so hypertumors have more time to evolve. So, in large organisms, cancer may be more common and less lethal. We illustrate this hypothesis in silico using a previously published hypertumor model. Results from the model predict that malignant neoplasms in larger organisms should be disproportionately necrotic, aggressive, and vascularized than deadly tumors in small mammals. These predictions may serve as the basis on which to test the hypothesis, but to our knowledge, no one has yet performed a systematic investigation of comparative necrosis, histopathology, or vascularization among mammalian cancers.
46
Cancer: Principles and Practice of Oncology.
Annals of Internal Medicine · 1991 · 8.5K citations
Medicine, Oncology, Oncology Nursing +10
Guns, Germs, and Steel: The Fates of Human Societies.
Garrett Hardin, Jared M. Diamond · Population and Development Review · 1997 · 5.1K citations
Humanities, Anthropology, History +15
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine O′Brien, Aaron Pollett, Steven Gallinger et al. · Nature · 2006 · 4.1K citations
Medicine, Cancer Biology, Oncology +11
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci‐Vitiani, Dario Lombardi, Emanuela Pilozzi et al. · Nature · 2006 · 4K citations
Medicine, Cancer Biology, Oncology +12
Vascular endothelial growth factor (VEGF) and its receptors
Gera Neufeld, Tzafra Cohen, Stela Gengrinovitch et al. · The FASEB Journal · 1999 · 3.5K citations
Medicine, Cell Biology, Oncology +17